Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 35
Filter
2.
Neurobiol Learn Mem ; 155: 508-518, 2018 11.
Article in English | MEDLINE | ID: mdl-30081154

ABSTRACT

After reactivation, a previously consolidated memory can enter into a labile state followed by a re-stabilization process defined as reconsolidation. The aim of this study was to explore whether an existing negative autobiographical memory can be modified by using a non-invasive interference (audiovisual positive preparation) after reactivation and to determine if this effect could be dependent on the reconsolidation process. We found that the presentation of a positive inductor after a negative autobiographical memory reactivation may lead to a change in the emotional information of the original trace and that such effect can be mediated by the reconsolidation process. The modification of the memory has been shown in women only. These results suggest that a positive audiovisual induction may play a potential role in psychotherapeutic techniques for the modification of dysfunctional autobiographical memories.


Subject(s)
Emotions , Memory Consolidation , Memory, Episodic , Acoustic Stimulation , Adolescent , Adult , Female , Humans , Male , Mental Recall , Photic Stimulation , Young Adult
3.
Rev. esp. pediatr. (Ed. impr.) ; 72(4): 230-242, jul.-ago. 2016. tab, graf
Article in Spanish | IBECS | ID: ibc-156768

ABSTRACT

La sexualidad es un componente esencial de la personalidad. Durante la adolescencia -de 10 a 19 años- se producen cambios físicos, psíquicos y hormonales que junto a las transformaciones sociales, favorecen el inicio de conductas de riesgo. A pesar de los esfuerzos realizados para mejorar la salud sexual y reproductiva en los adolescentes y jóvenes españoles por parte de las familias y la sociedad, ellos continúan siendo vulnerables frente a los embarazos y las ITS. Nuestra investigación tiene lugar en el Centro de Primera Acogida de Protección ‘Hortaleza’ que pertenece al Instituto Madrileño de la Familia y el Menor, donde ingresan los/las adolescentes españoles e inmigrantes bajo la condición de guarda o tutela con edades comprendidas desde los 14,9 años hasta los 17,9 años, en la Comunidad de Madrid. Nuestro objetivo es describir las variables cuantitativas de los/las adolescentes ingresados en el centro durante el periodo 2013-2014 y analizar las variables cualitativas de las menores que acudieron a la Consulta de Planificación Familiar (AU)


Sexuality is an essential part of personality. During adolescence -10 to 19 years of age- several physical, psychic, and hormonal changes take place. These changes, together with social transformations, give rise to risk behaviour. In spite of the efforts made by the families and the society to improve the sexual and reproductive health of Spanish youths, they are still vulnerable to unplanned pregnancy and STDs. Our research was carried out in the institution Preliminary Reception Centre for Protection ‘Hortaleza’, which belongs to the Institute for the Child and Family in Madrid, where Spanish and immigrant children and teenagers between the ages of 14.9 and 17.9 are received under custody or tutelage. Our aim is to describe the quantitative variables for adolescents admitted in the Centre between 2013 and 2014 and analyse the qualitative variables for the girls under the age of 18 who turned to our Family Planning Counselling (AU)


Subject(s)
Humans , Male , Female , Child , Adolescent , Young Adult , Sexuality , Sex Education , Pregnancy in Adolescence/prevention & control , Sexually Transmitted Diseases/prevention & control , Spain , Orphanages , Social Marginalization , Pregnancy, Unwanted
4.
Immunobiology ; 213(2): 133-41, 2008.
Article in English | MEDLINE | ID: mdl-18241697

ABSTRACT

We have recently shown that sodium caseinate (CasNa) was able to inhibit the proliferation of the myeloid cell line 32D cl3 in a non-toxic way, and that it also induced the expression of macrophage colony-stimulating factor (M-CSF). Casein is the main protein present in milk and is composed of alpha (alpha), beta (beta) and kappa (kappa) subunits. This work was undertaken to evaluate if any one casein is responsible for the proliferation and differentiation properties found for CasNa on myeloid cells. Taking into consideration that 32D cl3 cells are considered to be non-malignant and dependent on IL-3 for proliferation, we also included for this study a leukemic cell line, WEHI-3, that does not depend on any external growth factor for its proliferation in order to evaluate if the growth inhibitory effect of caseins is also present for malignant cells. Our results showed that all caseins were inhibitory for the proliferation of either 32D cl3 and WEHI-3 and that only the 32D cl3 cells were induced to differentiate into the monocyte-macrophage lineage. In order to evaluate if CasNa was able to inhibit the proliferation of other myeloid cells we used J774 and P388 and found that they were also inhibited. We also determined that the different caseins exhibit different differentiation properties, with alpha-casein being the only one able to induce the secretion of M-CSF. We consider this work to open a new field of research, where casein, or its components, can be studied for their possible role in hematopoiesis and on the inhibition of malignant cell proliferation for therapeutic use.


Subject(s)
Caseins/pharmacology , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Myeloid Cells/drug effects , Animals , Caseins/classification , Cell Line, Tumor , Cells, Cultured , Mice , Myeloid Cells/pathology , RNA, Messenger/biosynthesis , Reverse Transcriptase Polymerase Chain Reaction
5.
Neuroscience ; 142(4): 979-90, 2006 Nov 03.
Article in English | MEDLINE | ID: mdl-16934411

ABSTRACT

Animals made dependent via an ethanol (ETOH) -containing liquid diet (6% v/v) for 14 days were subjected to a contextual fear conditioning paradigm 3 days after the last consumption day. After conditioning, rats were subjected to four extinction trials by exposing the animals to the conditioned context and their freezing was evaluated for each trial. Immediately after the first extinction trial, animals were injected with D-cycloserine (DCS) 5 mg/kg i.p., a dose that did not influence the extinction in control rats. Spontaneous recovery of learned fear was tested seven days after the last extinction trial. The following day, animals were subjected to a reacquisition or a reinstatement procedure and their freezing responses evaluated 24 h later. The present study shows that: 1. discontinuation from chronic ETOH administration facilitated the formation of a new fear memory concomitant with a marked resistance to being extinguished, 2. administration of DCS (5 mg/kg) facilitated the extinction process only in ETOH withdrawn rats, 3. both reinstatement and reacquisition procedures restored the increased freezing in ETOH withdrawn animals after extinction, 4. DCS administered immediately after the first extinction trial prevented the increase in freezing following both reacquisition and reinstatement. The enhanced sensitivity to the facilitatory effect of DCS in ETOH withdrawn animals may be mediated by adaptive changes in N-methyl-D-aspartate (NMDA) receptor provoked by ETOH dependence.


Subject(s)
Alcohol-Induced Disorders, Nervous System/physiopathology , Cycloserine/pharmacology , Ethanol/adverse effects , Fear/drug effects , Memory/drug effects , Substance Withdrawal Syndrome/physiopathology , Alcohol-Induced Disorders, Nervous System/psychology , Animals , Antimetabolites/pharmacology , Anxiety Disorders/chemically induced , Anxiety Disorders/physiopathology , Anxiety Disorders/psychology , Brain/drug effects , Brain/metabolism , Brain/physiopathology , Brain Chemistry/drug effects , Brain Chemistry/physiology , Central Nervous System Depressants/adverse effects , Conditioning, Psychological/drug effects , Conditioning, Psychological/physiology , Disease Models, Animal , Drug Synergism , Extinction, Psychological/drug effects , Extinction, Psychological/physiology , Fear/physiology , Male , Memory/physiology , Rats , Rats, Wistar , Receptors, N-Methyl-D-Aspartate/drug effects , Receptors, N-Methyl-D-Aspartate/metabolism , Substance Withdrawal Syndrome/psychology , Synaptic Transmission/drug effects , Synaptic Transmission/physiology
6.
Neuroscience ; 139(3): 831-42, 2006.
Article in English | MEDLINE | ID: mdl-16542779

ABSTRACT

The current research examines the influence of midazolam (MDZ) on memory reconsolidation using a contextual fear paradigm in rats, based on three context-shock training trials (0.7 mA, 3 s). First, we evaluate the effect of MDZ (1 mg/kg, i.p.) injected shortly after the training procedure. Second, we examined the influence of MDZ after a brief exposure (90 s) either in the training context (reactivation procedure) or in a neutral environment (no reactivation procedure) and one day later, freezing behavior was scored when rats were re-exposed to the training environment. Third, we investigate both the effect of MDZ administered at different times following reactivation on fear memory and the persistence of such effect 10 days after reactivation. Finally, we test whether the MDZ effect could be reverted by a single weak training trial (0.2 mA, 3 s) or by the presentation of the same unconditioned stimulus in the absence of the conditioned stimulus as a reminder which proves to induce significant freezing in rats not previously trained. Results show that MDZ interferes with the formation of a contextual fear memory only when administered after the reactivation procedure but not after the training procedure. This interference was effective up to 60 min after reactivation and not at a later time. No spontaneous recovery of freezing behavior was observed 11 days after MDZ injection which was not reverted by a weak training trial and by the unconditioned stimulus alone. All these data support the idea that stimulating GABA A receptor sites via MDZ selectively disrupts the reconsolidation process of a contextual fear memory.


Subject(s)
Brain/drug effects , Fear/drug effects , GABA Modulators/pharmacology , Memory/drug effects , Midazolam/pharmacology , Retention, Psychology/drug effects , Animals , Association Learning/drug effects , Brain/physiology , Conditioning, Classical/drug effects , Electroshock , Male , Rats , Rats, Wistar , Time Factors
8.
Rev Neurol ; 38(5): 401-5, 2004.
Article in Spanish | MEDLINE | ID: mdl-15029514

ABSTRACT

BACKGROUND: Atrial fibrillation is present in 24% of the population over 60 and it increases the risk of stroke by 2,4% 3%/year. Antithrombotic treatment is considered as the treatment of choice for cardioembolic stroke prevention in this patients. As far as we know there are not relevant data about the influence of these treatments on the type of stroke that may develop in these patients. AIM: Analyze whether there are differences in the clinical profile and functional prognosis after stroke in patients with atrial fibrillation depending on the type of treatment they were on at the time of occurrence of the event. PATIENTS AND METHODS: We identified 67 patients who were admitted consecutively to our stroke unit with a stroke and atrial fibrillation over a period of 2 years. Patients were classified according to the type of antithrombotic treatment they were on. Functional prognosis was estimated by Rankin score at discharge. RESULTS: Treated patient showed a non significant tendency to suffer less severe strokes and present a better functional situation at discharge than those who were not on prophylactic treatment. Treated patients had a significant higher prevalence of previous TIA (44,2% vs 9,1%; p= 0,0042) and HBP (81,4% vs 52%; p= 0,041) than non treated patients. Embolic strokes were more frequent in non treated patients. CONCLUSION: Antithrombotic treatment not only prevents strokes but may also contribute to the development of less severe strokes with a better functional prognosis in patients with AF and does not contribute to increase complications in these group of patients.


Subject(s)
Atrial Fibrillation/complications , Fibrinolytic Agents/therapeutic use , Stroke/prevention & control , Aged , Aged, 80 and over , Atrial Fibrillation/classification , Brain Damage, Chronic/epidemiology , Brain Damage, Chronic/etiology , Brain Damage, Chronic/prevention & control , Brain Ischemia/drug therapy , Brain Ischemia/epidemiology , Brain Ischemia/etiology , Brain Ischemia/prevention & control , Cerebral Infarction/drug therapy , Cerebral Infarction/epidemiology , Cerebral Infarction/etiology , Cerebral Infarction/prevention & control , Cohort Studies , Comorbidity , Drug Evaluation , Female , Fibrinolytic Agents/pharmacology , Humans , Intracranial Embolism/drug therapy , Intracranial Embolism/epidemiology , Intracranial Embolism/etiology , Intracranial Embolism/prevention & control , Ischemic Attack, Transient/epidemiology , Male , Platelet Aggregation Inhibitors/therapeutic use , Prevalence , Prognosis , Retrospective Studies , Risk Factors , Severity of Illness Index , Spain/epidemiology , Stroke/classification , Stroke/drug therapy , Stroke/epidemiology , Stroke/etiology
9.
Rev. neurol. (Ed. impr.) ; 38(5): 401-405, 1 mar., 2004. tab
Article in Es | IBECS | ID: ibc-30901

ABSTRACT

Background. Atrial fibrillation is present in 2-4% of the population over 60 and it increases the risk of stroke by 2,4-3% per year. Antithrombotic treatment is considered as the treatment of choice for cardioembolic stroke prevention in this patients. As far as we know there are not relevant data about the influence of these treatments on the type of stroke that may develop in these patients. Aim. Analyze whether there are differences in the clinical profile and functional prognosis after stroke in patients with atrial fibrillation depending on the type of treatment they were on at the time of occurrence of the event. Patients and methods. We identified 67 patients who were admitted consecutively to our stroke unit with a stroke and atrial fibrillation over a period of 2 years. Patients were classified according to the type of antithrombotic treatment they were on. The clinical picture was evaluated by the Canadian scale. Functional prognosis was estimated by Rankin score at discharge. Results. Treated patient showed a non-significant tendency to suffer less serious strokes and present a better functional situation at discharge than those who were not on prophylactic treatment. Treated patients had a significant higher prevalence of previous TIA (44,2% vs 9,1%; p = 0,0042) and HBP (81,4% vs 52%; p = 0,041) than non-treated patients. Embolic strokes were more frequent in non-treated patients. Conclusion. Antithrombotic treatment not only prevents strokes but may also contribute to the development of less serious strokes with a better functional prognosis in patients with AF and does not contribute to increase complications in these group of patients (AU)


Introducción. La fibrilación auricular (FA) aparece en el 2-4 por ciento de la población mayor de 60 años y hace aumentar el riego de ictus en un 2,4-3 por ciento por año. El tratamiento antitrombótico es el tratamiento de elección para prevenir los ictus de origen embólico. No existen datos relevantes sobre la influencia de estos tratamientos en el tipo de ictus que aparece en estos pacientes. Objetivo. Analizar si existen diferencias en la clínica y el pronóstico funcional entre pacientes con ictus y FA según se traten o no. Pacientes y métodos. Hemos incluido a 67 pacientes que ingresaron consecutivamente en nuestra Unidad de Ictus con FA asociada al ictus durante un período de 2 años. Hemos clasificado a los pacientes de acuerdo con el tipo de tratamiento profiláctico que recibían. Estimamos la clínica inicial mediante la escala canadiense, y la situación funcional al alta, mediante la escala de Rankin. Resultados. Encontramos una tendencia estadísticamente no significativa a una clínica menos grave al ingreso y un mejor estado funcional al alta a favor de los tratados respecto los no tratados. También encontramos diferencias significativas a favor de los tratados en cuanto a los antecedentes de accidente isquémico transitorio (44,2 por ciento frente a 9,1 por ciento; p = 0,0042) y a HTA (81,4 por ciento frente a 52 por ciento; p = 0,041), así como una mayor proporción de ictus embólicos en los no tratados. Conclusión. El tratamiento antitrombótico adecuado en un paciente con FA podría asociarse, en caso de aparecer un ictus, a una clínica inicial menos grave y un mejor estado funcional final respecto los no tratados sin aumentar el número de complicaciones (AU)


Subject(s)
Male , Adult , Aged, 80 and over , Aged , Child , Female , Humans , Middle Aged , Adolescent , Headache Disorders , Health Services Needs and Demand , Ischemic Attack, Transient , Stroke , Cohort Studies , Comorbidity , Cerebral Infarction , Drug Evaluation , Fibrinolytic Agents , Intracranial Embolism , Platelet Aggregation Inhibitors , Prevalence , Prognosis , Retrospective Studies , Risk Factors , Ambulatory Care Facilities , Spain , Analgesics , Delivery of Health Care , Prospective Studies , Atrial Fibrillation , Brain Ischemia , Severity of Illness Index , Brain Injury, Chronic
12.
Rev. chil. cir ; 54(6): 605-610, 2002. tab, graf
Article in Spanish | LILACS | ID: lil-342187

ABSTRACT

Antecedentes: El cáncer de la vesícula biliar (CaVB) persiste como una neoplasia frecuente, y en general del mal pronóstico. Los tratamientos utilizados hasta la fecha son diversos, pero en general coinciden en la práctica de una resección quirúrgica de aseo, asociado o no a esquemas de neoadyuvancia y adyuvancia, ya sean éstos de quimio y/o radioterapia. Objetivo: Describir los resultados de un protocolo de tratamiento para CaVB en diferentes estadios de la enfermedad. Material y Método: Estudio observacional, descriptivo y prospectivos para valorar un esquema terapeútico en pacientes con CaVB, realizado entre julio de 1994 y julio de 2000. Se trataron consecutivamente a todos los pacientes colecistectomizados cuyo estudio histológico reveló carcinoma infiltrante de la vesícula biliar y se encontraban en etapas intermedias y avanzadas de la enfermedad. Para ello, se realizó bisegmentectomía parcial de los segmentos IV y V del hígado y linfadenectomía regional, asociada a una adyuvancia con quimioterapia ambulatoria en base a 5-FU y leucovorina (6 ciclos). Con un seguimiento promedio de la serie de 35,6 meses, se valoró evolución, morbilidad, mortalidad operatoria, y supervivencia actuaria. Se realizó un análisis exploratorio descriptivo de los datos y análisis de supervivencia. Resultados: Fueron incluidos en este protocolo 20 pacientes, con una edad promedio de 60,9 años (42-85 años), de los cuales 15 son mujeres (75 por ciento). Nivel de invasión: muscular 5 pacientes (25 por ciento), subserosa 6 casos (30 por ciento), serosa 6 pacientes (30 por ciento), y grasa perivesicular 3 casos (15 por ciento). La morbilidad de la serie fue de 30 por ciento. No hubo mortalidad operatoria. La quimioterapia fue bien tolerada, y sólo un paciente no la completó pues falleció antes. La supervivencia actuarial global de la serie fue de 76,5 por ciento a los 60 meses. Conclusiones: El tratamiento realizado es satisfactorio desde el punto de vista de la morbilidad y mortalidad, con una supervivencia actuarial global y por estadio, dentro de rangos aceptables


Subject(s)
Humans , Male , Adult , Female , Middle Aged , Cholecystectomy , Gallbladder Neoplasms , Postoperative Complications , Reoperation/statistics & numerical data , Treatment Outcome
13.
Brain Res ; 891(1-2): 236-46, 2001 Feb 09.
Article in English | MEDLINE | ID: mdl-11164828

ABSTRACT

This study investigated the effect of chronic benzodiazepine (BZD) administration and its abrupt discontinuation on later subsequent ethanol consumption employing a free choice paradigm between water and increasing ethanol concentrations. In addition, we also studied the anxiolytic and reinforcing properties of ethanol assessed in the elevated plus maze (EPM) and in the conditioned place preference paradigm, respectively. Adult male Wistar rats were subjected to a chronic diazepam (DZM) treatment (2 mg/kg/day, i.p.) during 21 days. Twenty-four hours after that treatment and, in another experiment, 10 days after the last DZM injection, rats were subjected to an oral ethanol self-administration procedure (ethanol was increased in concentration (v/v) on 4 consecutive days as follows: 2%, 4%, 6%, 8% followed by an additional period of 8 days in which animals were offered a 10% (v/v) ethanol solution. Diazepam treated rats showed a higher ethanol intake and spontaneous signs of ethanol withdrawal when the access to ethanol was discontinued. These results were observed when ethanol was available at day 1 of withdrawal but not when DZM treated rats were initiated in the ethanol choice test 10 days after BDZ withdrawal. Furthermore, DZM treated rats exhibited an increased anxiolytic ethanol induced effect (1 g/kg, i.p.) in the EPM and a significant ethanol-induced conditioned place preference (1 g/kg, i.p.). These data suggest that early DZM treatment facilitates ethanol consumption and the development of ethanol dependence.


Subject(s)
Alcoholism/etiology , Benzodiazepines/pharmacology , Drug Interactions/physiology , Ethanol/pharmacology , Alcoholism/metabolism , Alcoholism/physiopathology , Animals , Anti-Anxiety Agents/pharmacology , Diazepam/pharmacology , Dose-Response Relationship, Drug , Drug Administration Schedule , Male , Rats , Rats, Wistar , Substance Withdrawal Syndrome/etiology , Substance Withdrawal Syndrome/physiopathology , Time Factors
15.
Clin Chem ; 45(6 Pt 1): 777-84, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10351985

ABSTRACT

BACKGROUND: Amplified DNA probes provide powerful tools for the detection of infectious diseases, cancer, and genetic diseases. Commercially available amplification systems suffer from low throughput and require decontamination schemes, significant hands-on time, and specially trained laboratory staff. Our objective was to develop a DNA probe system to overcome these limitations. METHODS: We developed a DNA probe system, the BDProbeTecTMET, based on simultaneous strand displacement amplification and real-time fluorescence detection. The system uses sealed microwells to minimize the release of amplicons to the environment. To avoid the need for specially trained labor, the system uses a simple workflow with predispensed reagent devices; a programmable, expandable-spacing pipettor; and the 96-microwell format. Amplification and detection time was 1 h, with potential throughput up to 564 patient results per shift. We tested 122 total patient specimens obtained from a family practice clinic with the BD ProbeTecET and the Abbott LCx(R) amplified system for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae. RESULTS: Based on reportable results, the BDProbeTecET results for both organisms were 100% sensitive and 100% specific relative to the LCx. CONCLUSIONS: The BDProbeTecET is an easy-to-use, high-throughput, closed amplification system for the detection of nucleic acid from C. trachomatis and N. gonorrhoeae and other organisms.


Subject(s)
DNA Probes , Gene Amplification , Chlamydia trachomatis/genetics , DNA, Bacterial/analysis , DNA, Bacterial/urine , Fluorescence , Humans , Neisseria gonorrhoeae/genetics , Reagent Kits, Diagnostic , Sensitivity and Specificity
16.
Rev. méd. Chile ; 127(4): 389-98, abr. 1999. tab, graf
Article in Spanish | LILACS | ID: lil-243909

ABSTRACT

Background: The possible relationship of stress or heat-shock proteins (hsp) with the pathogenesis of autoimmune disease has been intensely studied recently. In adult rheumatoid arthritis, a bacterial hsp (65 kDa hsp from Mycobacterium tuberculosis or bovis) would have a cross reactivity with a hsp of ARTICULAR cartilage. Aim: To assess the cellular immune response to the 65 kA hsp from M Bovis in children. Patients and methods: The proliferative response of peripheral mononuclear cells of 20 children with juvenile chronic polyarthritis and 20 healthy controls, against the 65 kDa hsp and other antigenic fractions from M bovis, was studied. Results: Patients with juvenile chronic polyarthritis had a intense reaction against 65 kDa fraction and a second fraction located between 32.5 and 27.5 kDa. Patients with a prolonged evolution of the disease (more than five years), reacted preferentially to an antigenic segment located between 32.5 and 27.5 kDa and those with a shorter evolution did so with an antigen of 27.5-18.5 kDa. Conclusions: These results support the hypothesis that 65 kDa hsp from M bovis is involved in the pathogenesis of chronic juvenile polyarthritis and suggest that patients with short or prolonged evolutions of the disease would react to different antigenic fractions


Subject(s)
Humans , Male , Female , Child, Preschool , Arthritis/immunology , T-Lymphocytes/immunology , Mycobacterium bovis/immunology , Arthritis/drug therapy , Aspirin/therapeutic use , Electrophoresis , Antibody Formation/immunology , Heat-Shock Proteins/immunology
17.
Brain Res ; 819(1-2): 40-7, 1999 Feb 20.
Article in English | MEDLINE | ID: mdl-10082859

ABSTRACT

The effect of benzodiazepine (BDZ) withdrawal on escape acquisition and on the behavioral response to two different reinforcing stimuli was investigated. In addition, the influence of antidepressant drugs (AD) differing in their mechanism of action on these behavioral outputs was also evaluated. Rats subjected to withdrawal from a chronic treatment with diazepam (DZM; 2 mg/kg per day, i.p.) during 21 days were subsequently exposed to a brief inescapable shock session (IS) and 48 h later to an active avoidance test. Only withdrawn animals exposed to the IS exhibited enhanced escape failures. In an additional experiment, withdrawn rats were repeatedly administered with vehicle (VEH), desipramine (DMI; 5 mg/kg, i.p.), fluoxetine (FLU; 5 mg/kg, i.p.) or phenelzine (PHEN; 5 mg/kg, i.p.) and subsequently exposed to IS and to active avoidance task. A significant reversal of escape deficit was only observed following DMI and PHEN but not after FLU. Furthermore, withdrawn rats showed a reduced preference for a sexually relevant olfactory cue, this reduced sensitivity was only normalized following DMI but not after the administration of FLU or PHEN. Finally, rats exposed to abrupt cessation of chronic BDZ administration did not exhibit preference for a context previously associated with amphetamine (AMP) under the conditioned place preference (CPP) procedure. All these findings are indicative that BDZ withdrawal facilitates the subsequent occurrence of behavioral changes-escape failures and reduced behavioral response to rewarding stimuli-suggested to parallel important symptoms of human depression. In addition, DMI seems to be much more effective in restoring such behavioral abnormalities as compared to a MAO inhibitor and to a inhibitor of 5-HT uptake.


Subject(s)
Anti-Anxiety Agents/toxicity , Antidepressive Agents/pharmacology , Diazepam/toxicity , Escape Reaction/drug effects , Substance Withdrawal Syndrome/drug therapy , Amphetamine/pharmacology , Animals , Avoidance Learning/drug effects , Conditioning, Classical/drug effects , Cues , Desipramine/pharmacology , Electroshock , Fluoxetine/pharmacology , Male , Odorants , Phenelzine/pharmacology , Rats , Sexual Behavior, Animal/drug effects , Time Factors
19.
Rev Med Chil ; 123(6): 707-12, 1995 Jun.
Article in Spanish | MEDLINE | ID: mdl-8525223

ABSTRACT

The purpose of this work was to construct and assess a scale aimed to detect risky relationships between mothers and newborns that could predict future child abuse and neglect. The instrument was applied in two opportunities, by a trained midwife and by an expert in mental health, to a sample of 106 mother-newborn dyads. When both assessments were compared, the concordance to assess relationship risk was 99.3%. The reliability of the scale, measured with the Crombach, an internal consistence index, was 0.88. Those items with a low discriminative capacity were eliminated. The massive use of the resultant scale, that is easy to apply and highly reliable, could help to prevent child abuse and neglect.


Subject(s)
Mother-Child Relations , Evaluation Studies as Topic , Female , Humans , Infant, Newborn , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...